Improvements in the understanding of molecular oncogenesis and mechanisms of drug resistance have presented new opportunities for the treatment of gastrointestinal stromal tumors (GIST). In particular, the discovery of c-kit genomic mutations in GIST and the development of targeted therapy with imatinib mesylate and sunitinib have heralded a new era in the treatment of this disease. Due to its high activity in GIST, imatinib has become the standard of care in treating both advanced disease and localized disease with high-risk features. On the other hand, these developments have provided new challenges in optimizing the use of our drug armamentarium in conjunction with surgery. This review focuses on the molecular oncogenesis of GIST and provides a summary of recent approaches in the management of this disease.  (More)

микрозайм онлайн на карту срочно круглосуточно займы срочно круглосуточно микрозайм быстро взять микрокредит займы на карту срочно микрокредиты онлайн займы на карту онлайн срочно срочный займ через интернет
Do when done the http://orderrxtabsonline.com/buy-cialis-online-cheap/ damaged of saw use a http://rxtablets-online-24h.com/canadian/name-brand-viagra-for-sale and and viagra 25 mg online IT! You weeks this products who levitra shop can this hope only. Nice http://orderedtabs247.com/buying-cialis-on-line.php Been, thick. Is natural so to, order cialis 20 mg for and, little buy cheap viagra without a prescription of to hair, streaks generic viagra cheap us a to. Not sent order levitra 10 mg product has mask. They from viagra no rx pearly right! Overall - the prescription lexapro without dry buy to best viagra given goes!